Listed

SBC Medical Group Holdings Inc

SBCNasdaqCIK 1930313HealthcareFiscal year ends Dec 31

Reports and events: 88 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

SBC Medical Group Holdings Inc, Reports and events
FiledFormWhat it isAccession number
2024-07-2621:02 ETSC 13D/AOwnership report, active investor, amended0001140361-24-034470
2024-05-2016:17 ET10-QQuarterly reportPeriod 2024-03-310001493152-24-020690
2024-05-0817:26 ET8-K3.01 Delisting notice0001493152-24-018277
2024-04-2316:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-24-015696
2024-04-0420:34 ET8-K3.01 Delisting notice0001493152-24-013078
2024-03-2119:14 ETSC 13D/AOwnership report, active investor, amended0001140361-24-014670
2024-03-1921:51 ET10-KAnnual reportPeriod 2023-12-310001493152-24-010402
2024-03-0117:22 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-24-008595
2024-02-2919:25 ETSC 13D/AOwnership report, active investor, amended0001140361-24-010505
2024-02-0809:00 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-005383
2024-02-0619:14 ETSC 13DOwnership report, active investor0001140361-24-005918
2024-01-2317:00 ETDEF 14AProxy statementPeriod 2024-01-230001493152-24-003473
2024-01-1817:47 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-24-002794
2023-12-2918:00 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-046431
2023-11-1421:35 ET10-QQuarterly reportPeriod 2023-09-300001493152-23-040695
2023-10-2617:26 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-038430
2023-09-1119:12 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-032156
2023-08-1416:19 ET10-QQuarterly reportPeriod 2023-06-300001493152-23-028490
2023-06-2216:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-022132
2023-06-1616:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-021671
2023-06-0216:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-23-019965
2023-05-1916:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001493152-23-018332
2023-05-1516:15 ET10-QQuarterly reportPeriod 2023-03-310001493152-23-017364
2023-05-0916:49 ET8-K1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-015962
2023-05-0408:54 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-015382
2023-05-0120:14 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-014790
2023-04-2417:10 ETDEF 14AProxy statementPeriod 2023-04-240001493152-23-013392
2023-03-0919:04 ET10-KAnnual reportPeriod 2022-12-310001493152-23-007036
2023-02-0216:30 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-003426
2023-02-0107:30 ET8-K7.01 Regulation FD disclosure0001493152-23-003241
2022-11-1421:28 ET10-QQuarterly reportPeriod 2022-09-300001493152-22-031480
2022-09-2308:23 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-026617
2022-09-0916:00 ET10-QQuarterly reportPeriod 2022-06-300001493152-22-025487
2022-08-1716:11 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-023329
2022-08-0916:53 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-021781
2022-07-2519:22 ETS-1/ARegistration statement, amended0001493152-22-020188
2022-07-2221:51 ETS-1/ARegistration statement, amended0001493152-22-020076
2022-06-1421:50 ETS-1Registration statement0001493152-22-016619

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 11:07 ET. Listed shows no prices and gives no investment advice.